Shortening the NIH Stroke Scale for use in the prehospital setting

被引:78
作者
Tirschwell, DL
Longstreth, WT
Becker, KJ
Gammans, RE
Sabounjian, LA
Hamilton, S
Morgenstern, LB
机构
[1] Univ Washington, Harborview Med Ctr, Sch Med, Dept Neurol, Seattle, WA 98104 USA
[2] Univ Washington, Harborview Med Ctr, Sch Med, Dept Epidemiol, Seattle, WA 98104 USA
[3] MSM INCARA Pharmaceut Corp, Res Triangle Pk, NC USA
[4] Aeolus Pharmaceut Inc, Res Triangle Pk, NC USA
[5] Interneuron Pharmaceut Inc, Lexington, MA USA
[6] Stanford Univ, Sch Med, Dept Neurol, Stanford, CA 94305 USA
[7] Univ Michigan, Dept Neurol, Ann Arbor, MI USA
关键词
cerebrovascular accident; emergency medical services;
D O I
10.1161/01.STR.0000044166.28481.BC
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and Purpose-Prehospital stroke scales should identify stroke patients and measure stroke severity. The goal of this study was to identify a subset of the 15 items in the National Institutes of Health Stroke Scale (NIHSS-15) that measures stroke severity and predicts outcomes. Methods-Using 2 distinct data sets from acute stroke clinical trials, we derived and validated shortened versions of the NIHSS (sNIHSS). Stepwise logistic regression and bootstrap techniques were used in selection of NIHSS-15 items. Areas under the receiver operator characteristic curve (C statistics) were used to compare predictive performance of logistic models incorporating differing versions of the NIHSS. Results-The derivation analyses suggested the 8 NIHSS-15 items that were most predictive of "good outcome" 3 months after stroke, in order of decreasing importance: right leg item, left leg, gaze, visual fields, language, level of consciousness, facial palsy, and dysarthria. The sNIHSS-8 comprises all 8 and the sNIHSS-5, the first 5. In the validation models, C statistics were NIHSS-15=0.80, sNIHSS-8=0.77, and sNIHSS-5=0.76. Statistical comparisons suggested that the NIHSS-15 had better predictive performance than the sNIHSS-8 or the sNIHSS-5; the absolute difference in C statistics was small. There was no significant difference between the sNIHSS-8 and the sNIHSS-5. Conclusions-Much of the predictive performance of the full NIHSS-15 was retained with a shortened scale, the sNIHSS-5. Shortening the NIHSS-15 will facilitate its use during prehospital evaluations. The sNIHSS severity information may be useful to triage acute stroke patients in communities and to provide a baseline stroke severity for prehospital acute stroke trials.
引用
收藏
页码:2801 / 2806
页数:6
相关论文
共 41 条
[1]   Baseline NIH Stroke Scale score strongly predicts outcome after stroke - A report of the Trial of Org 10172 in Acute Stroke Treatment (TOAST) [J].
Adams, HP ;
Davis, PH ;
Leira, EC ;
Chang, KC ;
Bendixen, BH ;
Clarke, WR ;
Woolson, RF ;
Hansen, MD .
NEUROLOGY, 1999, 53 (01) :126-131
[2]   ENSURING RELIABILITY OF OUTCOME MEASURES IN MULTICENTER CLINICAL-TRIALS OF TREATMENTS FOR ACUTE ISCHEMIC STROKE - THE PROGRAM DEVELOPED FOR THE TRIAL OF ORG-10172 IN ACUTE STROKE TREATMENT (TOAST) [J].
ALBANESE, MA ;
CLARKE, WR ;
ADAMS, HP ;
WOOLSON, RF ;
BENDIXEN, BH ;
DAVIS, PH ;
JACOBY, MR ;
GOMEZ, FJ ;
DYKEN, ME ;
UC, EY ;
WOJCIESZEK, JM ;
KAPPELLE, LJ ;
TANNA, AB ;
MITCHELL, VL ;
GOMEZ, CR ;
MALKOFF, MD ;
TULYAPRONCHOTE, R ;
SAUER, CM ;
RIAZ, G ;
SCHMIDT, JG ;
MALIK, MM ;
BANET, GA ;
KARANJIA, PN ;
MADDEN, KP ;
RUGGLES, KH ;
MICKEL, SF ;
GOTTSCHALK, PG ;
HANSOTIA, PL ;
SORENSON, RW ;
JACOBSON, DM ;
HINER, BC ;
MANCL, K ;
LUKASIK, E ;
BRUNO, A ;
LAKIND, ED ;
JEFFREY, DR ;
MLADINICH, EK ;
IQBAL, J ;
REINERS, M ;
BARRETT, DW ;
SHIBUYA, D ;
WILLIAMS, JK ;
RUSSELL, P ;
KING, MK ;
CHAPIN, JE ;
CARTER, S ;
JEFFRIES, L ;
HIER, DB ;
SHAPIRO, RA ;
BRINT, SU .
STROKE, 1994, 25 (09) :1746-1751
[3]  
[Anonymous], 1998, INTRO BOOTSTRAP
[4]   MEASUREMENTS OF ACUTE CEREBRAL INFARCTION - A CLINICAL EXAMINATION SCALE [J].
BROTT, T ;
ADAMS, HP ;
OLINGER, CP ;
MARLER, JR ;
BARSAN, WG ;
BILLER, J ;
SPILKER, J ;
HOLLERAN, R ;
EBERLE, R ;
HERTZBERG, V ;
RORICK, M ;
MOOMAW, CJ ;
WALKER, M .
STROKE, 1989, 20 (07) :864-870
[5]   A randomized efficacy trial of citicoline in patients with acute ischemic stroke [J].
Clark, WM ;
Williams, BJ ;
Selzer, KA ;
Zweifler, RM ;
Sabounjian, LA ;
Gammans, RE .
STROKE, 1999, 30 (12) :2592-2597
[6]   A randomized dose-response trial of citicoline in acute ischemic stroke patients [J].
Clark, WM ;
Warach, SJ ;
Pettigrew, LC ;
Gammans, RE ;
Sabounjian, LA .
NEUROLOGY, 1997, 49 (03) :671-678
[7]   Recombinant tissue-type plasminogen activator (alteplase) for ischemic stroke 3 to 5 hours after symptom onset - The ATLANTIS study: A randomized controlled trial [J].
Clark, WM ;
Wissman, S ;
Albers, GW ;
Jhamandas, JH ;
Madden, KP ;
Hamilton, S .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (21) :2019-2026
[8]  
Davis PH, 1998, NEUROLOGY, V50, pA214
[9]   Progression in acute stroke - Value of the initial NIH Stroke Scale score on patient stratification in future trials [J].
DeGraba, TJ ;
Hallenbeck, JM ;
Pettigrew, KD ;
Dutka, AJ ;
Kelly, BJ .
STROKE, 1999, 30 (06) :1208-1212
[10]   A reappraisal of reliability and validity studies in stroke [J].
DOlhaberriague, L ;
Litvan, I ;
Mitsias, P ;
Mansbach, HH .
STROKE, 1996, 27 (12) :2331-2336